So, are weight loss drugs safe, and are there any potential dangers?

In 2025, medical consensus has shifted to viewing obesity as a chronic, relapsing disease that requires lifelong care, similar to hypertension or type 2 diabetes.

Recent guidelines and studies emphasize that while GLP-1 drugs (like semaglutide and tirzepatide) are highly effective, they are increasingly seen as long-term maintenance tools rather than short-term fixes. 

So far, studies do show the benefits do outweigh the problems. Of, course, the drugs are new and there is no information yet on their long term use, but they are seen as a very positive tool in helping cope with the obesity epidemic.

The main problem is that the weight that does come off for people using the drugs is not all fat. The drugs also reduce other tissues, such as bone and muscle, and any course of treatment should also be balanced with other ways of making sure the person replaces and rebuilds these kinds of tissues.

Other tools, such as changing lifestyle, good diet choices and developing new behaviours, are also key to both losing the weight, and keeping it off in a healthy way.

I’ve taken a look at a number of the latest studies, and some key points to note are:

1. Shift to Chronic Management

• Lifelong Dependency: New WHO guidelines (December 2025) recommend GLP-1 therapies for the long-term treatment of obesity.
• Weight Regain Risks: Clinical data shows that stopping the medication often leads to significant weight regain. A one-year follow-up to the STEP 1 trial found participants regained roughly two-thirds of their lost weight after discontinuation.
• “Food Noise” Return: Patients report that once treatment stops, the “food noise” (constant background hunger) often returns immediately. 

2. Expanding Health Benefits Beyond Weight

Long-term use is now linked to a “litany” of positive health outcomes beyond simple weight reduction: 

• Cardiovascular: A 2025 meta-analysis confirmed significant reductions in all-cause mortality and major adverse cardiovascular events (MACE).
• Liver & Kidney: Clinical trials (like FLOW and ESSENCE) demonstrated substantial benefits for chronic kidney disease and MASH (fatty liver disease).
• Emerging Areas: Ongoing research in 2025 is investigating potential protective effects against Alzheimer’s, Parkinson’s, and even certain obesity-related cancers (endometrial, ovarian). 

3. Long-Term Safety and Tolerability

• Digestive Risks: The most consistent long-term risks are gastrointestinal, including an elevated risk of gallbladder and biliary disorders with prolonged use (>26 weeks).
• Muscle Loss: Concerns remain about losing lean muscle mass (approximately 25% of total weight lost). Experts recommend high protein intake and resistance training to mitigate this.
• Psychiatric Safety: Large-scale 2025 reviews by regulators (like the UK’s MHRA) concluded there is no causal link between GLP-1s and increased suicidal ideation. 

4. Real-World Practicalities in 2025

Prescribing Hurdles: Demand continues to outpace capacity, leading to concerns about “postcode lotteries” and inequitable access between public and private patients.  In the UK, 2.5 million people have already been prescribed GLP-1 courses.

Adherence Challenges: Despite their benefits, persistence is difficult; real-world data indicates roughly half of patients discontinue within one year, often due to cost or side effects.

Microdosing: A growing 2025 trend involves “microdosing” (taking lower-than-prescribed doses) to manage side effects or costs, though it remains largely unstudied in clinical trials.

The real message seems clear. It is early days with these drugs. They clearly do work, but the side effects can be really quite uncomfortable, and they shouldn’t be seen as the only tool in the box for someone who struggles to keep the weight off. The best solution, if you are going to use them, is to also take advice on what else you need to do. You also want to keep yourself healthy, both mentally and physically.

Work on yourself as well as your weight to understand how you came to gain the weight in the first place, and find the right support to keep you on track on your weight loss journey.